Position
Chief Executive Officer
Company
Dyne Therapeutics
WalthamBiotechnologyHealth CareTherapeuticsDescription
Dyne Therapeutics announces the appointment of John Cox as President, CEO, and member of the Board of Directors, effective immediately. The former CEO, Joshua Brumm, has chosen to step down to pursue a career in healthcare investing and will serve as an advisor to ensure a seamless transition.
Quick answer
John Cox Named President and CEO of Dyne Therapeutics (March 25, 2024). Dyne Therapeutics is based in Waltham, Massachusetts, United States.
- Who is the new Chief Executive Officer at Dyne Therapeutics?
- Dyne Therapeutics named John Cox Chief Executive Officer, announced March 25, 2024.
- What did Dyne Therapeutics announce on March 25, 2024?
- Dyne Therapeutics announces the appointment of John Cox as President, CEO, and member of the Board of Directors, effective immediately. The former CEO, Joshua Brumm, has chosen to step down to pursue a career in healthcare investing and will serve as an advisor to ensure a seamless transition.
- What does Dyne Therapeutics do?
- Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
- Where is Dyne Therapeutics based?
- Dyne Therapeutics is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- AVEO Pharmaceuticals (March 25, 2024), Poseida Therapeutics, Inc. (March 25, 2024), Bicara Therapeutics (March 26, 2024) and Rocket Pharmaceuticals (March 26, 2024) also announced leadership changes within 45 days of Dyne Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AVEO Oncology Appoints Edgar E. Braendle as Chief Medical Officer (March 25, 2024)
- Poseida Therapeutics Appoints Syed Rizvi as Chief Medical Officer (March 25, 2024)
- Bicara Therapeutics Appoints Jeltje Schulten as SVP of Clinical and Medical Affairs and Rita Dalal as Vice President of Clinical Development (March 26, 2024)
- Rocket Pharmaceuticals, Inc. Appoints Aaron Ondrey as Chief Financial Officer (March 26, 2024)
- IDRx Appoints Dr. David P. Kerstein as Chief Medical Officer (March 27, 2024)
- Transgene appoints Lucie Larguier as Chief Financial Officer and promotes Christelle Schwoerer to Chief Human Resources Officer (March 27, 2024)
Who to call at Dyne Therapeutics, and when
A new leader at Dyne Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Dyne Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dyne Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dyne Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dyne Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Dyne Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.